Mainstream

Intellia targets 1,200 patients in expanded Phase III ATTR cardiomyopathy trial as enrollment accelerates

Intellia targets 1,200 patients in expanded Phase III ATTR cardiomyopathy trial as enrollment accelerates

Post ContentntlaRead More

You might also be interested in reading Tesla runs software update to address recall of 239K vehicles.

August 8, 2025
In Mainstream